PT XL Axiata Tbk/ US69369R1005 /
20/05/2024 21:48:47 | Var. +0.2600 | Volume | Denaro- | Lettera- | Max | Min |
---|---|---|---|---|---|---|
2.9300USD | +9.74% | 2,030 Fatturato: 6,064.9575 |
-Quantità in denaro: - | -Quantità in lettera: - | 3.4425 | 2.7300 |
GlobeNewswire
10:00
Heineken Silver is on a mission to end bitterness, starting with one of the biggest love-hate relati...
GlobeNewswire
10:00
UP Fintech Holding Limited to Report First Quarter 2024 Financial Results on June 5, 2024
GlobeNewswire
10:00
LUNA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Luna Innovations Incorporated ...
GlobeNewswire
10:00
AXTI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that AXT Inc Investors with Substan...
GlobeNewswire
10:00
PERI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Perion Network Ltd. Investors ...
GlobeNewswire
10:00
ALT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Altimmune, Inc. Investors with ...
GlobeNewswire
10:00
HRBR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Harbor Diversified, Inc. Inves...
GlobeNewswire
10:00
Medigene's Global Research & Collaboration Agreement with BioNTech to Extend Beyond Initially Announ...
GlobeNewswire
09:30
NewHydrogen CEO Steve Hill Discusses Development of Standalone Hydrogen Evolution System with SDSU E...
GlobeNewswire
09:15
HEALWELL AI’s Pentavere Partners with Sunnybrook and Successfully Demonstrates its AI Powered Clinic...
Newsfile Corp
09:05
Great Eagle Gold Corp. Now Trading on U.S. OTC Market and Announces Timely Private Placement Opportu...
GlobeNewswire
09:00
NEXEN TIRE’s official partner of Manchester City crowned 2023/24 Premier League Champions
GlobeNewswire
09:00
CancerVax Successfully Uses Nobel Prize Chemistry to Achieve Universal Cancer Vaccine Targeting Mile...